Skip to main content
TVTX filings

Corporate insider profile

William E. Rote Filing Activity

Latest reported as Chief Research Officer of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$477,152.85
Latest transaction
May 6, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 6, 2026Travere Therapeutics, Inc. (TVTX)Chief Research OfficerSale2,763$43.95$121,434
Apr 22, 2026Travere Therapeutics, Inc. (TVTX)Chief Research OfficerSale9,100$39.09$355,719